"It"s not just how high your antibodies go, but how good they are," Dubovsky explains. "We have data from early clinical studies showing that our vaccine was able to generate neutralising antibodies that are very high level. So these aren"t just antibodies that can recognise the spike protein, but they can actually stop the virus from spreading."